Cargando…
Short and Long-Term Effects of the Exposure of Breast Cancer Cell Lines to Different Ratios of Free or Co-Encapsulated Liposomal Paclitaxel and Doxorubicin
Background: Associating paclitaxel (PTX) to doxorubicin (DXR) is one of the main chemotherapy strategies for breast cancer (BC) management. Protocols currently available consist in administering both drugs on their maximum tolerated dose, not taking into account the possible differences in efficacy...
Autores principales: | Franco, Marina Santiago, Roque, Marjorie Coimbra, Oliveira, Mônica Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523953/ https://www.ncbi.nlm.nih.gov/pubmed/30979090 http://dx.doi.org/10.3390/pharmaceutics11040178 |
Ejemplares similares
-
Long-Circulating and Fusogenic Liposomes Loaded with Paclitaxel and Doxorubicin: Effect of Excipient, Freezing, and Freeze-Drying on Quality Attributes
por: Roque, Marjorie, et al.
Publicado: (2022) -
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
por: Franco, Marina Santiago, et al.
Publicado: (2021) -
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022) -
Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine
por: Jiang, Xing, et al.
Publicado: (2017) -
Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel
por: Nguyen, Thi Lan, et al.
Publicado: (2017)